Biohaven Ltd. — Regulatory Filings 2022

Sep 20, 2022

CORRESP 1 filename1.htm html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk Copyright 2022 Workiva Document

Biohaven Ltd.

215 Church Street

New Haven, CT 06510

September 20, 2022

Via EDGAR

Securities and Exchange Commission,

Division of Corporation Finance,

Office of Life Sciences,

100 F Street, N.E.,

Washington, D.C. 20549-9303.

Attention:
Mary Mast
Tyler Howes
Jason Drory
Re:	Acceleration Request for Biohaven Ltd.
	Registration Statement on Form 10 (File No. 001-41477)

Ladies and Gentlemen:

Pursuant to Section 12(d) of the Securities Exchange Act of 1934, as amended, and Rule 12d1-2 promulgated thereunder, Biohaven Ltd. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form 10, Registration Number 001-41477 (the “Registration Statement”), be accelerated so that the Registration Statement will become effective at 3:00 p.m., Eastern Time, on September 22, 2022, or as soon as practicable thereafter.

Please contact Robert W. Downes of Sullivan & Cromwell LLP via telephone at (212) 558-4312 or via e-mail at (downesr@sullcrom.com) with any questions and please notify him when this request for acceleration has been granted.

---

/s/ Vlad Coric, M.D.
Name:	Vlad Coric, M.D.
Title:	Chief Executive Officer

cc:
(Sullivan & Cromwell LLP)